EAM
Empirical Asset Management’s Vertex Pharmaceuticals VRTX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-65,763
| Closed | -$126K | – | 468 |
|
|
2024
Q4 | $126K | Buy |
65,763
+63,874
| +3,381% | +$123K | 0.04% | 327 |
|
|
2024
Q3 | $879K | Buy |
+1,889
| New | +$879K | 0.31% | 92 |
|
|
2023
Q2 | – | Sell |
-2,377
| Closed | -$749K | – | 183 |
|
|
2023
Q1 | $749K | Buy |
+2,377
| New | +$749K | 0.72% | 48 |
|
|
2022
Q2 | – | Sell |
-2,692
| Closed | -$703K | – | 181 |
|
|
2022
Q1 | $703K | Buy |
2,692
+827
| +44% | +$216K | 0.67% | 48 |
|
|
2021
Q4 | $410K | Buy |
+1,865
| New | +$410K | 0.4% | 92 |
|